MedTrace Logo

Intensity Modulated Radiotherapy With Concomitant Boost in Breast Cancer

NCT03471741 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 451

Last updated 2018-03-21

No results posted yet for this study

Summary

To assess feasibility of postoperative IMRT with concomitant boost in moderate-high risk breast cancer in terms of late toxicity and local control

Conditions

Interventions

RADIATION

IMRT with concomitant boost

RADIATION

3D-RT with sequential boost

Sponsors & Collaborators

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

    lead OTHER

Principal Investigators

  • Alessio G Morganti, MD · Radiation Oncology Center, Department of Experimental, Diagnostic and Speciality Medicine-DIMES, Unversity of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-06-01
Primary Completion
2017-12-31
Completion
2017-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03471741 on ClinicalTrials.gov